01 Record
CVE-2021-43935
ICSMA-21-343-01 Hillrom Welch Allyn Cardio Products
HighPUBLISHEDCNA: icscert
CNA base score8.1 CVSS v3.xCVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H
02 Description
ICSMA-21-343-01 Hillrom Welch Allyn Cardio Products
03 Exploitation and scoring
- Exploitation
- Not assessed. CISA has not published an exploitation assessment for this record, and it is not in the KEV catalog. That is an absence of assessment, not a finding of no risk.
- SSVC decision
- Not assessed by CISA
- EPSS probability
- 1.14% probability of exploitation activity in the next 30 days.
- EPSS percentile
- Equal to or higher than the score of 66.2% of scored records. A rank, not a probability.
- NVD base score
- 9.8 (CVSS v3.x), scored by the NVD independently of the CNA.
- NVD CVSS vector
- CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
- NVD analysis status
- Modified. NVD last modified this record on 2026-06-17.
- Red Hat severity
- No Red Hat rating. Red Hat rates the CVEs that affect its products.
Exploit-prediction scores from FIRST. Independent scoring and analysis status from the NVD. Vendor severity from Red Hat. Exploitation assessment and catalog membership from CISA.
04 Metadata
- Published
- 2021-12-15 18:05Z4 YR AGO
- Last updated
- 2024-09-16 23:11Z2 YR AGO
- Reserved
- 2021-11-16
- Assigning CNA
- icscert
- Record state
- PUBLISHED
- Severity
- High (CVSS 8.1)
- CNA CVSS vector
- CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H
- Weaknesses
- Data version
- 5.1
- Document digest
- 6e592bd8450aea28b1df40c5b9bc9f46638da2b55d71818cbd4071479ba76a7c
05 Affected products
VendorProductVersionsPlatforms
06 References
07 Remediation
Hillrom recommends users upgrade to the latest product versions when updated products are available. Information on how to update these products to their new versions can be found on the Hillrom disclosure page.